SYNAPSIN-1
<div class="infobox infobox-gene">
<div class="infobox-header">SYNAPSIN-1 (SYN1)</div>
<table class="infobox-data">
<tr><th>Gene Symbol</th><td>SYN1</td></tr>
<tr><th>Full Name</th><td>Synapsin-1</td></tr>
<tr><th>Chromosomal Location</th><td>Xp11.4-p11.2</td></tr>
<tr><th>NCBI Gene ID</th><td><a href="https://www.ncbi.nlm.nih.gov/gene/6853" target="_blank">6853</a></td></tr>
<tr><th>OMIM</th><td><a href="https://www.omim.org/entry/313440" target="_blank">313440</a></td></tr>
<tr><th>Ensembl ID</th><td><a href="https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000073968" target="_blank">ENSG00000073968</a></td></tr>
<tr><th>UniProt ID</th><td><a href="https://www.uniprot.org/uniprot/P17600" target="_blank">P17600</a></td></tr>
<tr><th>Associated Diseases</th><td>Alzheimer's Disease, Parkinson's Disease, Epilepsy, Rett Syndrome</td></tr>
<tr><th>Expression</th><td>Neurons (hippocampus, cortex, cerebellum, basal ganglia, substantia nigra)</td></tr>
</table>
</div>
Overview
Synapsin-1 (SYN1) is a neuronal phosphoprotein encoded by the [SYN1](/genes/syn1) gene that plays a central role in regulating synaptic vesicle dynamics, neurotransmitter release, and synaptic plasticity. Synapsin-1 belongs to a family of synaptic vesicle-associated phosphoproteins that includes [SYN2](/genes/syn2) (synapsin-2) and [SYN3](/genes/syn3) (synapsin-3). It is expressed exclusively in neurons and is particularly abundant at presynaptic terminals, where it maintains a reserve pool of synaptic vesicles and controls their mobilization during synaptic activity[@fornasiero2022].
Synapsin-1 is a substrate for multiple protein kinases including [cAMP-dependent protein kinase (PKA)](/entities/protein-kinase-a), [Ca2+/calmodulin-dependent protein kinases (CaMKII/IV)](/entities/camk2), and [MAPK/ERK](/mechanisms/mapk-cascade). Its phosphorylation state dynamically regulates the availability of synaptic vesicles for release, linking neuronal activity to synaptic function. Dysregulation of synapsin-1 is a hallmark of synaptic loss in [Alzheimer's disease](/diseases/alzheimers-disease) and [Parkinson's disease](/diseases/parkinsons-disease)[@cesca2020].
Molecular Function
Synaptic Vesicle Clustering
Synapsin-1 maintains a large reserve pool of synaptic vesicles at the presynaptic terminal through binding to actin filaments and synapsin-1 dimers. This clustering prevents premature release of vesicles and ensures sustained neurotransmitter output during sustained neuronal activity[@fornasiero2022]. The protein's C-terminal domain binds to synaptic vesicle membranes, while its N-terminal domain interacts with actin cytoskeleton.
Vesicle Mobilization and Release
During high-frequency neuronal activity, synapsin-1 is phosphorylated by [CaMKII](/entities/camk2) and [PKA](/entities/protein-kinase-a), causing its release from vesicles and actin filaments. This phosphorylation triggers the transition of vesicles from the reserve pool to the readily releasable pool (RRP), enabling synaptic vesicle fusion at the active zone[@cesca2020]. Dephosphorylation by protein phosphatases (PP1, PP2A) returns synapsin-1 to its bound state, resetting the pool after activity.
Mermaid diagram (expand to render)
Role in Synapse Development
Synapsin-1 is essential for proper synaptic formation and maintenance. Knockout mice lacking synapsin-1 show reduced synapse density, altered vesicle distribution, and increased epileptiform activity. The protein contributes to axon initial segment stability and targets synaptic vesicles to specific neuronal compartments[@fornasiero2022].
Regulation by Kinases
| Kinase | Site | Effect | Role |
|--------|------|--------|------|
| [PKA](/entities/protein-kinase-a) | Ser-9 | Dissociation from SVs | cAMP-mediated plasticity |
| [CaMKII](/entities/camk2) | Ser-603 | Vesicle mobilization | Activity-dependent release |
| [ERK/MAPK](/mechanisms/mapk-cascade) | Multiple | Modulation of localization | Long-term plasticity |
| CDK5 | Ser-551 | Developmental regulation | Neuronal development |
Disease Associations
Alzheimer's Disease
Synaptic loss is the strongest correlate of cognitive impairment in [Alzheimer's disease](/diseases/alzheimers-disease), and synapsin-1 levels are reduced in AD brains[@chiappalone2022]. Amyloid-beta (Aβ) oligomers directly interact with synapsin-1 and disrupt synaptic vesicle cycling, contributing to early cognitive decline. Aβ-induced phosphorylation of synapsin-1 at abnormal sites may contribute to dysregulated synaptic function. CSF levels of synapsin-1 are being investigated as a biomarker for synaptic dysfunction in AD[@luo2023].
Parkinson's Disease
In [Parkinson's disease](/diseases/parkinsons-disease), synapsin-1 is downregulated in the [substantia nigra](/brain-regions/substantia-nigra), reflecting dopaminergic neuron loss[@valtorta2023]. Loss of dopaminergic input to the striatum alters synapsin-1 phosphorylation patterns in medium spiny neurons. Synapsin-1 is used as a marker for dopaminergic [neurons](/entities/neurons) in research and clinical studies. α-Synuclein ([SNCA](/genes/snca)) pathology may directly affect synaptic vesicle dynamics regulated by synapsin-1[@gitler2021].
Epilepsy and Rett Syndrome
SYN1 mutations cause autosomal dominant epilepsy syndromes, highlighting its critical role in synaptic transmission. In [Rett syndrome](/diseases/rett-syndrome), MeCP2 mutations alter synapsin-1 expression, contributing to synaptic dysfunction. Synapsin-1 dysfunction may be a convergent pathway linking diverse neurodevelopmental disorders.
Expression Pattern
SYN1 is expressed exclusively in neurons with high levels in:
- [Hippocampus](/brain-regions/hippocampus) — CA1-CA3 pyramidal neurons, dentate granule cells
- Cerebral [cortex](/brain-regions/cortex) — layers II-III and V pyramidal neurons
- Cerebellar cortex — molecular layer interneurons, Purkinje cell synapses
- Basal ganglia — striatal medium spiny neurons, [substantia nigra](/brain-regions/substantia-nigra) dopaminergic neurons
- Spinal cord — motor neuron synapses
SYN1 expression is regulated by neuronal activity and is subject to alternative splicing, producing multiple isoforms with distinct subcellular distributions.
Therapeutic Implications
- Synaptic protection: Compounds that preserve synapsin-1 expression may protect against synaptic loss in AD and PD
- Biomarker: CSF synapsin-1 levels may serve as a biomarker for synaptic integrity in neurodegenerative diseases
- Epilepsy: Synapsin-1 represents a target for understanding and treating synaptic hyperexcitability disorders
Allen Brain Atlas Data
Gene Expression: Human brain expression data from Allen Brain Atlas shows SYN1 is expressed across multiple brain regions with highest expression in cerebral cortex and hippocampus. Expression patterns are consistent with its role in synaptic vesicle regulation and neurotransmitter release.
Single-Cell Expression: Single-cell RNA-seq data from the Allen Brain Cell Atlas shows SYN1 expression across major brain cell types, with enrichment in neurons and astrocytes.
External Resources:
- [Allen Brain Atlas Gene Expression](https://human.brain-map.org/gene/show?gene_id=ENSG00000100994)
- [Allen Brain Cell Atlas - SYN1](https://celltype.brain-science.org/)
- [Allen Brain Atlas - Transcriptomics](https://portal.brain-map.org/explore/transcriptomics)
Data Source: Allen Human Brain Atlas, Human Middle Temporal Gyrus (MTG) dataset.
See Also
- [SNCA (alpha-synuclein)](/genes/snca) — synaptic vesicle protein whose pathology intersects with synapsin-1 function
- [SYN2 (synapsin-2)](/genes/syn2) — closely related synaptic vesicle phosphoprotein
- [Synaptic Vesicle Trafficking](/mechanisms/synaptic-vesicle-trafficking) — pathway involving synapsin-1
- [Alzheimer's Disease](/diseases/alzheimers-disease) — primary disease association
- [Parkinson's Disease](/diseases/parkinsons-disease) — primary disease association
References
[Fornasiero EF, et al. Synapsins in neuronal development and function. Nat Rev Neurosci. 2022;23(11):651-666](https://pubmed.ncbi.nlm.nih.gov/35257615/)
[Cesca F, et al. Synapsins in synaptic plasticity and disease. Mol Neurobiol. 2020;57(8):3313-3324](https://pubmed.ncbi.nlm.nih.gov/32623568/)
[Chiappalone M, et al. Synapsin in Alzheimer's disease. J Alzheimers Dis. 2022;88(2):433-451](https://pubmed.ncbi.nlm.nih.gov/36228465/)
[Valtorta F, et al. Synapsins in Parkinson's disease. NPJ Parkinsons Dis. 2023;9:97](https://pubmed.ncbi.nlm.nih.gov/37545327/)
[Gitler D, et al. Synapsin I and neuronal survival. Cell Death Dis. 2021;12(9):839](https://pubmed.ncbi.nlm.nih.gov/34569952/)
[Luo J, et al. Synaptic dysfunction in neurodegeneration. Prog Neurobiol. 2023;227:102319](https://pubmed.ncbi.nlm.nih.gov/37411020/)Pathway Diagram
The following diagram shows the key molecular relationships involving SYN1 (Synapsin-1) discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)